At the J.P. Morgan Healthcare Conference this week some of the biggest names in healthcare gathered to discuss the state of the biopharmaceuticals sector. Amidst all of the commotion, some executives took a moment to tell CNBC‘s Meg Tirrell which CEO (in any industry) they’d most like to trade places with if given the chance.
Biogen Idec CEO George Scangos chose Tesla Motors and SpaceX founder Elon Musk “because he started Tesla from the ground up, he did what other people said couldn’t be done. At the same time he had SpaceX. Those are two amazing companies and he’s an amazing guy.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Both Agios CEO David Schenkein and Actavis CEO Brent Saunders said they would like to trade places with an executive at Apple.
“I would have said Steve Jobs because I’m an Apple geek and I’ve been an Apple geek since the early ’80s,” Schenkein said.
Saunders picked current Apple CEO Tim Cook. “He’s innovative, disruptive and courageous … three qualities I highly admire.”
Ariad Pharmaceuticals founder Harvey Berger went with CEO of Disney, naming it the most interesting company in the world.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Acorda Therapeutics CEO Ron Cohen and Cigna President David Cordani both picked Virgin Group founder Richard Branson. And Merck CEO Kenneth Frazier showed his sense of humor when he said “I would be the CEO of the Philadelphia Eagles because maybe I could help them win.”
